Polyphosphazene Immunoadjuvants for Intradermal Vaccine Delivery

Polyphosphazenes for Biomedical Applications

Volumn , Issue , 2008, Pages 101-116

  Andrianov, Alexander K ^a   Decollibus, Daniel P ^a   Gillis, Helice A ^a   Kha, Henry H ^a   Marin, Alexander ^a  

^a Apogee Technology Inc   (United States)

Author keywords

Poly di(carboxylatophenoxy)phosphazene (PCPP); Polyphosphazene immunoadjuvants; Polyphosphazene immunoadjuvants for intradermal vaccine delivery

Indexed keywords

EID: 77956525004     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470478882.ch7     Document Type: Chapter

References (23)

1. Alarcon, J.B., Hartley, A.W., Harvey, N.G., Mikszta, J.A. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin. Vaccine Immunol., 2007, 14(4):375-381.
2. Belshe, R.B., Newman, F.K., Cannon, J., Duane, C., Treanor, J., Van Hoecke, C., Howe, B.J., Dubin, G. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med., 2004, 351(22):2286-2294.
3. Glenn, G.M., Kenney, R.T., Hammond, S.A., Ellingsworth, L.R. Transcutaneous immunization and immunostimulant strategies. Immunol. Allergy Clin. of North Am., 2003, 23(4):787-813.
4. Hooper, J.W., Golden, J.W., Ferro, A.M., King, A.D. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine, 2007, 25(10):1814-1823.
5. Kenney, R.T., Frech, S.A., Muenz, L.R., Villar, C.P., Glenn, G.M. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med., 2004, 351(22):2295-2301.
6. La Montagne, J.R., Fauci, A.S. Intradermal influenza vaccination: Can less be more? N. Engl. J. Med., 2004, 351(22):2295-2301.
7. Prausnitz, M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Revi., 2004, 56(5):581-587.
8. Prausnitz, M.R., McAllister, D.V., Kaushik, S., Patel, P.N., Mayberry, J.L., Allen, M.G. Microfabricated microneedles for transdermal drug delivery. Am. Soci. Mech. Engi., Bioeng. Div. (Publ.), 1999, 42, 89-90.
9. Singh, M, ed. Vaccine Adjuvants and Delivery Systems. Wiley-Interscience, Hoboken, NJ, 2006.
10. Vogelbruch, M., Nuss, B., Kãrner, M., Kapp, A., Kiehl, P., Bohm, W. Aluminiuminduced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy, 2000, 55(9):883-887.
11. Andrianov, A.K. Water-soluble polyphosphazenes for biomedical applications. J. Inorg. Organomet. Polym. Mater., 2006, 16(4):397-406.
12. Andrianov, A.K., Chen, J. Polyphosphazene microspheres: Preparation by ionic complexation of phosphazene polyacids with spermine. J. Appl. Polym. Sci., 2006, 101(1):414-419.
13. Andrianov, A.K., Svirkin, Y.Y., LeGolvan, M.P. Synthesis and biologically relevant properties of polyphosphazene polyacids. Biomacromolecules, 2004, 5(5):1999-2006.
14. Andrianov, A.K. Polyphosphazenes as vaccine adjuvants. In Vaccine Adjuvants and Delivery Systems. Singh, M., ed., Wiley, Hoboken, NJ, 2007, pp. 355-378.
15. Gill, H.S., Prausnitz, M.R. Transdermal drug delivery via coated microneedles. AIChE Annual Meeting, Conference Proceedings. 2005.
16. Gill, H.S., Prausnitz, M.R. Coating formulations for microneedles. Pharm. Res., 2007, 24(7):1369-1380.
17. Gill, H.S., Prausnitz, M.R. Coated microneedles for transdermal delivery. J. Controll. Release, 2007, 117(2):227-237.
18. Bouveret Le Cam, N.N., Ronco, J., Francon, A., Blondeau, C., Fanget, B. Adjuvants for influenza vaccine. Res. Immunol., 1998, 149(1):19-23.
19. Thongcharoen, P., Suriyanon, V., Paris, R.M., Khamboonruang, C., de Souza, M.S., Ratto-Kim, S., Karnasuta, C., Polonis, V.R., Baglyos, L., El Habib, R. A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J. Acquir. Immune Defici. Syndro, 2007, 46(1):48.
20. Payne, L.G., Jenkins, S.A., Woods, A.L., Grund, E.M., Geribo, W.E., Loebelenz, J.R., Andrianov, A.K., Roberts, B.E. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine, 1998, 16(1):92-98.
21. Andrianov, A.K., Marin, A., Roberts, B.E. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Biomacromolecules, 2005, 6(3):1375-1379.
22. Andrianov, A.K., Chen, J., Payne, L.G. Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. Biomaterials, 1998, 19(1-3): 109-115.
23. Andrianov, A.K., Payne, L.G. Protein release from polyphosphazene matrices. Adv. Drug Deliv. Rev., 1998, 31(3):185-196.